Trasylol is a clotting drug usually given to patients after cardiac surgery. Two studies published in the New England Journal of Medicine strongly suggest that Trasylol is dangerous. The first study looked at 10,000 patients who underwent bypasses at Duke University Medical Center from 1996 through 2005. It found that 6.4 percent of patients who were given Trasylol died within 30 days of the surgery, a rate nearly 2.5 times higher than patients who received a different drug, or who received no treatment for bleeding. The second study, financed by Bayer, looked at about 78,000 patients nationwide from 2003 to 2006. Researchers found that the risk of death was 64 percent higher in the Trasylol group than in those taking another medication. If you were given Trasylol during or after surgery and suffered kidney failure, or a family member was given Trasylol after surgery and then passed away unexpectedly, please contact us.
your next step . . .
Fill out a form for a free case reviewCall us: (212) 732-6408